Clinical Trials Study
Copyright ©The Author(s) 2015.
World J Psychiatr. Mar 22, 2015; 5(1): 138-146
Published online Mar 22, 2015. doi: 10.5498/wjp.v5.i1.138
Table 3 Response, remission, and depression score changes by groups
VariableAfrican-Americans (n = 41)Caucasians (n = 24)P-value1
Response, 50% reduction SIGH-SAD, n (%)33 (80.5)20 (83.3)0.78
Remission, SIGH-SAD < 8, n (%)19 (46.3)18 (75.0)0.02
SIGH-SAD, % change, mean ± SD-70.4 (22.7)76.0 (22.6)0.34
BDI-II, % change, mean ± SD-61.8 (32.2)-68.1 (32.9)0.46
POMS-A, % change, mean ± SD-46.6 (46.7)-46.8 (48.8)0.98
POMS-D, % change, mean ± SD-52.7 (47.1)-49.2 (54.9)0.78
Treatment days missed, mean ± SD8.7 (11.0)7.4 (8.3)0.61
Percent adherence, mean ± SD79.4 (26.2)82.4 (19.7)0.61